Janux Therapeutics JANX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 13.80 | 132.73 | -0.51 | -42,401 | -32 | |
| 2025Q3 | 24.44 | 144.99 | -0.39 | -35,251 | -24 | |
| 2025Q2 | 23.10 | 133.26 | -0.55 | -45,118 | -34 | |
| 2025Q1 | 27.00 | 148.45 | -0.38 | -34,897 | -24 | |
| 2024Q4 | 53.54 | 143.56 | -0.35 | -29,022 | -20 | |
| 2024Q3 | 45.43 | 127.74 | -0.53 | -35,842 | -28 | |
| 2024Q2 | 41.89 | 231.95 | -0.10 | -13,822 | -6 | |
| 2024Q1 | 37.65 | 136.59 | -0.30 | -20,161 | -15 | |
| 2023Q4 | 10.73 | 137.24 | -0.24 | -16,137 | -12 | |
| 2023Q3 | 10.08 | 136.70 | -0.24 | -15,813 | -12 | |
| 2023Q2 | 11.87 | 118.51 | -0.42 | -20,748 | -18 | |
| 2023Q1 | 12.10 | 116.16 | -0.42 | -20,281 | -17 | |
| 2022Q4 | 13.17 | 113.70 | -0.39 | -18,266 | -16 | |
| 2022Q3 | 13.54 | 107.94 | -0.40 | -18,022 | -17 | |
| 2022Q2 | 12.21 | 102.21 | -0.41 | -17,261 | -17 | |
| 2022Q1 | 14.34 | 100.98 | -0.32 | -13,542 | -13 | |
| 2021Q4 | 19.73 | 100.55 | -0.29 | -13,490 | -13 | |
| 2021Q3 | 21.63 | 101.27 | 0.42 | -10,903 | -11 | |
| 2021Q2 | 24.95 | 100.74 | 0.54 | -6,252 | -6 | |
| 2021Q1 | -2.06 | -2,284 | -2 |